BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12859993)

  • 1. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway.
    Lavelle D; DeSimone J; Hankewych M; Kousnetzova T; Chen YH
    Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
    Lepley DM; Pelling JC
    Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
    Shang D; Han T; Xu X; Liu Y
    Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
    Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
    Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
    Xiong J; Epstein RJ
    Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
    Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
    Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Kim BK; Lee YY
    Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
    Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
    Zhong D; Gu C; Shi L; Xun T; Li X; Liu S; Yu L
    J Cell Biochem; 2014 Sep; 115(9):1624-35. PubMed ID: 24788582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.